Gini Deshpande
Founder presso NuMedii, Inc.
Profilo
Gini Deshpande - Partner of Cathay Health
Gini Deshpande is Partner of Cathay Health.
She has over 20 years of experience creating new products and launching companies across a number of sectors in life sciences.
As founder and CEO of NuMedii, she pioneered the field of AI driven drug discovery, structured critical partnerships with Pharmaceutical partners and raised the Company’s initial rounds of financing.
Previously, as a consultant, she helped early stage platform companies Iperian and CollabRx identify optimal markets, enabling them to raise over $25M in financing.
At life sciences tools market leader Affymetrix, she was responsible for new product opportunities for their Academic Business Unit, their largest customer segment.
As director of the early stage incubation business unit at Children’s Hospital Boston (CHB), she secured grant funding to enable prototype development for six medical device products.
While at CHB, she helped launch several startups in the therapeutics and diagnostics space through collaborations with faculty.
She has also managed broad, diverse IP portfolios and closed licensing deals worth several million.
Gini has co-authored numerous papers and is the recipient of several awards.
She has served on the Advisory Committee of the BIO Investor Forum for several years and is a frequent speaker at industry conferences on AI in Healthcare.
She is an active advocate for increasing the participation of women in STEM and entrepreneurship and has also given talks at the United Nations on this topic.
She is also an angel investor in companies at the intersection of technology and healthcare.
She received her PhD in Biological Sciences from Purdue University and did post-doctoral work at Harvard Medical School.
Posizioni attive di Gini Deshpande
Società | Posizione | Inizio |
---|---|---|
NuMedii, Inc.
NuMedii, Inc. Miscellaneous Commercial ServicesCommercial Services NuMedii, Inc. discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies. Its Big Data technology, originally developed at Stanford University, utilizes large amounts of scientific data together with proprietary biological network-based algorithms to discover drug-disease connections and biomarkers that are predictive of efficacy. The firm translates these predictions into novel de-risked drug candidates and partners with pharmaceutical companies for development and commercialization. The company was founded by Gini Deshpande, Joel Dudley and Atul J. Butte in 2008 and is headquartered in Palo Alto, CA. | Founder | 01/01/2008 |
Cathay Capital Private Equity SAS
Cathay Capital Private Equity SAS Investment ManagersFinance Cathay Capital Private Equity SAS (Cathay Capital PE) is a private equity firm founded in 2007 by Mingpo Cai and Edouard Moinet. The firm is headquartered in Paris, France. | Private Equity Investor | 01/01/2021 |
Formazione di Gini Deshpande
Purdue University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Cathay Capital Private Equity SAS
Cathay Capital Private Equity SAS Investment ManagersFinance Cathay Capital Private Equity SAS (Cathay Capital PE) is a private equity firm founded in 2007 by Mingpo Cai and Edouard Moinet. The firm is headquartered in Paris, France. | Finance |
NuMedii, Inc.
NuMedii, Inc. Miscellaneous Commercial ServicesCommercial Services NuMedii, Inc. discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies. Its Big Data technology, originally developed at Stanford University, utilizes large amounts of scientific data together with proprietary biological network-based algorithms to discover drug-disease connections and biomarkers that are predictive of efficacy. The firm translates these predictions into novel de-risked drug candidates and partners with pharmaceutical companies for development and commercialization. The company was founded by Gini Deshpande, Joel Dudley and Atul J. Butte in 2008 and is headquartered in Palo Alto, CA. | Commercial Services |
- Borsa valori
- Insiders
- Gini Deshpande